What is Atara Biotherapeutics Inc?
engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and internationally. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 64.49M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 16,094 shares $39k | 1104,166 shares $1000k |
| 3-6months | 15,062 shares $41k | 0 |
| 6-9months | 11326,201 shares $3.3M | 1507,407 shares $4.7M |
| 9-12months | 180,554 shares $489k | 0 |